Pediatric ESAP 2021-2022

The Pediatric Endocrine Self-Assessment Program is a self-study curriculum aimed at physicians seeking initial certification or recertification in endocrinology, program directors interested in a testing and training instrument, and clinicians simply wanting a self-assessment and a broad review of endocrinology. Pediatric ESAP 2021-2022 consists of 100 brand-new multiple-choice questions in all areas of endocrinology, diabetes, and metabolism. There is extensive discussion of each correct answer and references. For accessibility for international practitioners, SI units are included.

Learning Options

Assess your clinical knowledge through 3 learning modes:

  • Pediatric ESAP 2021-2022 Learning Mode: This is the "traditional" PESAP. Answer 100 questions and receive immediate feedback and view the detail answer rationale. This mode must be completed in order to earn CME and MOC.
  • Mock Exam Mode: Perfect for simulating an exam. Retake this mock exam as often as you like and each time the questions will be re-organized. Feedback will be provided after completion of the exam.
  • Topical Learning Mode: Questions are organized by topical area.

 

Visit the online store to purchase.

Target Audience

Pediatric ESAP 2021-2022 is a self-study curriculum aimed at physicians seeking initial certification or recertification in pediatric endocrinology, program directors interested in a testing and training instrument, and clinicians simply wanting a self-assessment and a broad review of pediatric endocrinology.

Learning Objectives

Upon completion of this educational activity, participants will be able to:

  • Recognize clinical manifestations of pediatric endocrine, growth, and metabolic disorders and select among current options for diagnosis, management, and therapy.
  • Identify risk factors for endocrine and metabolic disorders in pediatric patients and develop strategies for prevention.
  • Evaluate pediatric endocrine and metabolic manifestations of systemic disorders.
  • Use current, evidence-based clinical guidelines and treatment recommendations to guide diagnosis and treatment of pediatric endocrine and metabolic disorders.

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Educator/Teacher
Competency Area: 
Professionalism
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
Endocrine Disruptors
General Endocrinology
Hormone Abuse
Growth Disorders
Health Disparities
Hormones and Cancer
Men’s Health
Neuroendocrinology and Pituitary
Nutrition
Obesity
Pediatric Endocrinology
Surgery
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Available credit: 
  • 40.00 ABP MOC
  • 40.00 AMA PRA Category 1 Credits
  • 40.00 CME Certificate of Participation
Course opens: 
02/19/2021
Course expires: 
12/31/2023
Pricing: 
Member
250
Non-Member
350
In-Training Member/Early Career Member
199
Rating: 
0

Liuska M. Pesce, MD, Program Chair (2020-present)
Clinical Associate Professor
Pediatric Thyroid Clinic Director
Stead Family Department of Pediatrics
Division of Pediatric Endocrinology and Diabetes
University of Iowa Carver College of Medicine

Paola A. Palma Sisto, MD, Program Chair (2017-2021)
Associate Professor
Medical College of Wisconsin
Children's Hospital of Wisconsin

Cem S. Demirci, MD
Pediatric Endocrinology
Director, Type 1 Diabetes Program
Connecticut Children’s Medical Center
Assistant Professor of Pediatrics 
Chase Family Chair in Juvenile Diabetes
University of Connecticut School of Medicine

Oscar Escobar, MD
Associate Professor
University of Pittsburgh School of Medicine
UPMC Children's Hospital of Pittsburgh

Reema L. Habiby, MD
Assistant Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Ann & Robert H. Lurie Children’s Hospital of Chicago

Ryan S. Miller, MD
Assistant Professor
University of Maryland School of Medicine

Ron Newfield, MD
Clinical Professor
University of California – San Diego
Rady Children’s Hospital San Diego

Sripriya Raman, MD
Pediatric Endocrinologist
K S Pediatrics

Li Chan, MD
Reader in Molecular Endocrinology and Metabolism
Honorary Consultant in Paediatric Endocrinology
Centre for Endocrinology
William Harvey Research Institute

Christine M. Trapp, MD
Pediatric Endocrinology, Connecticut Children's Medical Center
Assoicate Fellowship Director, Pediatric Endocrinology
Assistant Professor of Pediatrics
University of Connecticut School of Medicine

Halley Wasserman, MD
Assistant Professor of Pediatrics
Cincinnati Children's Hospital Medical Center
University of Cincinnati College of Medicine

Ari Wassner, MD
Medical Director, Thyroid Center
Director, Endocrinology Fellowship Training Director
Assistant Professor of Pediatrics
Boston Children's Hospital
Harvard Medical School

Abbie L. Young, MS, CGC, ELS(D)
Medical Editor

STATEMENT OF INDEPENDENCE

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s P-ESAP Faculty Working Group.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationships during the content development process for this activity: Ryan S. Miller, MD, is an NIH grantee. Ron Newfield, MD, is a principal investigator for Spruce and Neurocrine for new medications; a consultant for Spruce; a consultant and member of the Independent Safety Committee for Ascendis; a principal investigator for Merck; and a principal investigator for Zealand for dasiglucagon. Ari Wassner, MD, is a topic peer-reviewer for UpToDate (thyroid). Liuska Pesce, MD, has a spouse who is a consultant for Vidas Diagnostics and GlaxoSmithSline.

The following committee members reported no relevant financial relationships: 
Cem S. Demirci, MD; Oscar Escobar, MD; Reema L. Habiby, MD; Paola A. Palma Sisto, MD; Sripriya Raman, MD; Li Chan, MD; Christine M. Trapp, MD; Halley Wasserman, MD.

The medical editor for this program, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMERS

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

USE OF PROFESSIONAL JUDGMENT:

The educational content in this self-assessment test relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

DRUGS AND DOSAGES:

When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

This activity is not supported by educational grant(s) or other funds from any commercial supporter.

AMA PRA CATEGORY 1 CREDIT (CME) INFORMATION

To receive a maximum of 40.0 AMA PRA Category 1 Credits, participants must complete the online interactive module and activity evaluation located at education.endocrine.org. Participants must achieve a minimum score of 70% to claim CME credit. After initially completing the standard P-ESAP Learning Mode, if participants do not achieve a minimum score of 70%, they have the option to change their answers and make additional attempts to achieve a passing score. Learners also have the option to clear all answers and start over. Credit is only available on the standard P-ESAP Learning Mode.

METHOD OF PARTICIPATION

This enduring material is presented online and in print format. The estimated time to complete this activity, including review of material, is 40 hours. Participants must achieve a minimum score of 70% to claim CME credit and MOC points. After initially completing the module(s), if participants do not achieve a minimum score of 70%, they have the option to change their answers and make additional attempts to achieve a passing score. Participants also have the option to clear all answers and start over. Credit is only available on the standard P-ESAP Learning Mode.

SYSTEM REQUIREMENTS

To complete this activity, participants must have access to a computer or mobile device with an Internet connection and use a major Web browser, such as Internet Explorer 10+, Firefox 32+, Safari, or Google Chrome 37+. In addition, cookies and Javascript must be enabled in the browser’s options.

LAST REVIEW DATE: November 2020

ACTIVITY RELEASE DATE: February 2021

ACTIVITY EXPIRATION DATE: December 31, 2023 (date after which this enduring material is no longer certified for AMA PRA Category 1 Credits and ABP Medical Knowledge MOC points)

For questions about content or obtaining CME credit or MOC points, please contact the Endocrine Society at http://education.endocrine.org/contact.

Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring material for a maximum of 40.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 40 MOC points in the American Board of Pediatric’s (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Available Credit

  • 40.00 ABP MOC
  • 40.00 AMA PRA Category 1 Credits
  • 40.00 CME Certificate of Participation

To access Pediatric ESAP 2021-2022, you must first purchase it through the Endocrine Society online store and then login using your Society login credentials.

Required Hardware/software

To complete this activity, participants must have access to a computer or mobile device with an Internet connection and use a major Web browser, such as Internet Explorer 10+, Firefox 32+, Safari 7+, or Google Chrome 37+. In addition, cookies must be enabled in the browser’s options.